Short interfering RNA therapy dramatically lowers Lp(a) in phase 1 trial
Very hopeful news for Lipoprotein(a) patients
Related Articles
Clinicians Often Prefer Older, Generic Antibiotics Over Newer Ones for Gram-Negative Infections
A study finds that despite the development of some new agents for highly-resistant pathogens, prescribers are reluctant to utilize these therapies.
Welcoming the Era of Gene Editing in Medicine | NEJM
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
Agency for Healthcare Research and Quality (AHRQ)
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Comment period opens on creation of independent certification board of CV medicine
Progress has been made in the creation of a new independent Board of Cardiovascular Medicine under the American Board of Medical Specialties, several cardiology societies…
Excess Child Mortality Associated With Colombia’s Armed Conflict
This ecological cohort study estimates the proportion of infant and child mortality associated with armed conflict exposure from 1998 to 2019 in Colombia.
Yale School of Medicine collaboration to further clinical trial diversity
New Haven, Conn. — Yale School of Medicine and Equitable Breakthroughs in Medicine Development (EQBMED) — a multi-institute collaboration focused on clinical trial diversity —…
CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine
WASHINGTON (April 25, 2024) – Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm…
FY24 April Evergreen LP – Heart.org
Your gift now to the American Heart Association will help save lives by funding pioneering medical research, education and prevention information and more. For 100…
US respiratory virus levels continue to decline as officials track shift in SARS-CoV-2 proportions
Amid further declines in COVID activity, the CDC reported a steady rise in JN.1 spinoffs that have two added spike mutations, part of a group…
